What is NxStage’s System One?

The NxStage System One is the first and only truly portable hemodialysis system cleared for home use in the United States, including solo hemodialysis during waking hours, and nocturnal hemodialysis, while both the patient and care partner sleep. It was specifically designed for patients to use in their homes, and is small enough to allow patients to travel and bring their treatment supplies with them.


  • The easy-to-use drop-in cartridge allows for easy set-up and wipe-down after treatments

System One Cycler

  • This is the heart of the system that contains the fluid pumps and system controls
  • Simple interface is easy to understand and use
  • Its portability gives you the freedom to dialyze in any room of your house

PureFlow SL

  • Created dialysate using a combination of purified tap water and concentrated dialysate
  • Unlike convention hemodialysis systems, an electrical outlet and a tap connection are all that are required to operate

Nx2me Connected Health®

  • Shows treatment data on easy to read iPad screen
  • Makes it easy to collect and share treatment information with your clinic
  • Immediate access to information to address any alarms that may come up during treatment
Nx2me Connected Health<sup>®</sup>

Travel Setup

When traveling, bagged dialysate and a warmer are commonly used instead of PureFlow SL.

Dialysate Bag & Warmer

  • The Express Fluid Warmer delivers warmed dialysate from the dialysate bags to the cartridge
  • Pre-mixed dialysate bags can be used as an alternative to the PureFlow SL
  • By using dialysate bags patients have the freedom to dialyze wherever they go
The NxStage System one in it's 'travel' configuration
With the help of your doctor and care team, NxStage System One also allows you to determine where, when, and how frequently you will perform your treatments so they best meet your clinical and lifestyle needs. In addition, the Nx2me Connected Health app collects your treatment information directly from the cycler and provides flexible viewing, monitoring, and reporting, to your clinic to help reduce the burden of capturing information on paper flowsheets.
24/7 Technical Support is provided to all home patients and available even while traveling, adding another layer of confidence for patients and providers.

The reported benefits of home hemodialysis (HHD) may not be experienced by all patients.

The NxStage System is a prescription device and, like all medical devices, involves some risks. The risks associated with hemodialysis treatments in any environment include, but are not limited to, high blood pressure, fluid overload, low blood pressure, heart-related issues, and vascular access complications. When vascular access is exposed to more frequent use, infection of the site, and other access related complications may also be potential risks. The medical devices used in hemodialysis therapies may add additional risks including air entering the bloodstream, and blood loss due to clotting or accidental disconnection of the blood tubing set.

Home hemodialysis with the NxStage System during waking hours may not require a care partner, provided a physician and a qualified patient agree that solo home hemodialysis is appropriate. Patients performing nocturnal treatments are required to have a care partner. Care partners are trained on proper operation and how to get medical or technical help if needed.

Certain risks associated with hemodialysis treatment are increased when performing solo HHD because no one is present to help the patient respond to health emergencies. If patients experience needles coming out, blood loss, or very low blood pressure during solo HHD, they may lose consciousness or become physically unable to correct the health emergency. Losing consciousness or otherwise becoming impaired during any health emergency while alone could result in significant injury or death. Additional ancillary devices and training are required when performing solo HHD.

Certain risks associated with hemodialysis treatment are increased when performing nocturnal therapy due to the length of treatment time and because therapy is performed while the patient and care partner are sleeping. These risks include, but are not limited to, blood access disconnects and blood loss during sleep, blood clotting due to slower blood flow and/or increased treatment time, and delayed response to alarms when waking from sleep.

Patients should consult their doctor to understand the risks and responsibilities of performing these therapies using the NxStage System.